Address |
Phone |
Organization |
3012 E Main St, Suite F, Alton, TX 78573-0908 |
|
|
2102 Treasure Hills Blvd, Harlingen, TX 78550-8736 |
9562961437 |
UNIVERSITY OF TEXAS RIO GRANDE VALLEY |
1000 E Dove Ave, Dhr Family Health Center, Mcallen, TX 78504-3974 |
9563628677 |
UNIVERSITY OF TEXAS RIO GRANDE VALLEY |
3908 N Jackson Rd, Pharr, TX 78577-7768 |
9565025513 |
DILYDIS INC |
Measure Identifier |
Measure Title |
Performance Rate |
Reporting Mechanism |
ACI_EC_TRANS_EP_1 |
e-Prescribing |
97% |
|
ACI_EC_TRANS_EP_1 |
e-Prescribing |
97% |
|
ACI_EC_TRANS_EP_1 |
e-Prescribing |
97% |
|
ACI_EC_TRANS_HIE_1 |
Health Information Exchange |
0% |
|
ACI_EC_TRANS_HIE_1 |
Health Information Exchange |
0% |
|
ACI_EC_TRANS_HIE_1 |
Health Information Exchange |
0% |
|
ACI_EC_TRANS_MR_1 |
Medication Reconciliation |
93% |
|
ACI_EC_TRANS_MR_1 |
Medication Reconciliation |
93% |
|
ACI_EC_TRANS_MR_1 |
Medication Reconciliation |
93% |
|
ACI_EC_TRANS_PEA_1 |
Provide Patient Access |
0% |
|
ACI_EC_TRANS_PEA_1 |
Provide Patient Access |
0% |
|
ACI_EC_TRANS_PEA_1 |
Provide Patient Access |
0% |
|
ACI_EC_TRANS_PEA_2 |
View, Download, or Transmit (VDT) |
0% |
|
ACI_EC_TRANS_PEA_2 |
View, Download, or Transmit (VDT) |
0% |
|
ACI_EC_TRANS_PEA_2 |
View, Download, or Transmit (VDT) |
0% |
|
ACI_EC_TRANS_PHCDRR_1 |
Immunization Registry Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_1 |
Immunization Registry Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_1 |
Immunization Registry Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_2 |
Syndromic Surveillance Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_2 |
Syndromic Surveillance Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_2 |
Syndromic Surveillance Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_3 |
Specialized Registry Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_3 |
Specialized Registry Reporting |
% |
|
ACI_EC_TRANS_PHCDRR_3 |
Specialized Registry Reporting |
% |
|
ACI_EC_TRANS_PPHI_1 |
Security Risk Analysis |
% |
|
ACI_EC_TRANS_PPHI_1 |
Security Risk Analysis |
% |
|
ACI_EC_TRANS_PPHI_1 |
Security Risk Analysis |
% |
|
ACI_EC_TRANS_PSE_1 |
Patient-Specific Education |
97% |
|
ACI_EC_TRANS_PSE_1 |
Patient-Specific Education |
97% |
|
ACI_EC_TRANS_PSE_1 |
Patient-Specific Education |
97% |
|
ACI_EC_TRANS_SM_1 |
Secure Messaging |
0% |
|
ACI_EC_TRANS_SM_1 |
Secure Messaging |
0% |
|
ACI_EC_TRANS_SM_1 |
Secure Messaging |
0% |
|
MIPS_EC_110_overall |
Preventive Care and Screening: Influenza Immunization |
100% |
|
MIPS_EC_110_overall |
Preventive Care and Screening: Influenza Immunization |
100% |
|
MIPS_EC_110_overall |
Preventive Care and Screening: Influenza Immunization |
100% |
|
MIPS_EC_111_overall |
Pneumococcal Vaccination Status for Older Adults |
100% |
|
MIPS_EC_111_overall |
Pneumococcal Vaccination Status for Older Adults |
100% |
|
MIPS_EC_111_overall |
Pneumococcal Vaccination Status for Older Adults |
100% |
|
MIPS_EC_113_overall |
Colorectal Cancer Screening |
97% |
|
MIPS_EC_113_overall |
Colorectal Cancer Screening |
97% |
|
MIPS_EC_113_overall |
Colorectal Cancer Screening |
97% |
|
MIPS_EC_117_overall |
Diabetes: Eye Exam |
100% |
|
MIPS_EC_117_overall |
Diabetes: Eye Exam |
100% |
|
MIPS_EC_117_overall |
Diabetes: Eye Exam |
100% |
|
MIPS_EC_128_overall |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
100% |
|
MIPS_EC_128_overall |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
100% |
|
MIPS_EC_128_overall |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
100% |
|
MIPS_EC_130_overall |
Documentation of Current Medications in the Medical Record |
100% |
|
MIPS_EC_130_overall |
Documentation of Current Medications in the Medical Record |
100% |
|
MIPS_EC_130_overall |
Documentation of Current Medications in the Medical Record |
100% |
|
MIPS_EC_226_overall |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
100% |
|
MIPS_EC_226_overall |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
100% |
|
MIPS_EC_226_overall |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
100% |
|